Two Sigma Securities, LLC Immunic, Inc. Transaction History
Two Sigma Securities, LLC
- $5.78 Billion
- Q3 2024
A detailed history of Two Sigma Securities, LLC transactions in Immunic, Inc. stock. As of the latest transaction made, Two Sigma Securities, LLC holds 19,884 shares of IMUX stock, worth $20,281. This represents 0.0% of its overall portfolio holdings.
Number of Shares
19,884
Previous 17,107
16.23%
Holding current value
$20,281
Previous $18,000
77.78%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding IMUX
# of Institutions
71Shares Held
56.3MCall Options Held
100Put Options Held
350K-
Bvf Inc San Francisco, CA8.9MShares$9.08 Million0.47% of portfolio
-
Avidity Partners Management LP Dallas, TX8.27MShares$8.43 Million0.84% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT7.29MShares$7.44 Million1.02% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA5.59MShares$5.71 Million0.02% of portfolio
-
Janus Henderson Group PLC London, X05.1MShares$5.2 Million0.0% of portfolio
About IMMUNIC, INC.
- Ticker IMUX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 30,565,000
- Market Cap $31.2M
- Description
- Immunic, Inc., a clinical-stage biopharmaceutical company, develops a pipeline of selective oral immunology therapies for the treatment of chronic inflammatory and autoimmune diseases. Its lead development program is IMU-838, which is in Phase 2 clinical for treatment of relapsing-remitting multiple sclerosis, inflammatory bowel disease, and oth...